DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on August 25, 2006; DOI: 10.1124/dmd.106.010991


0090-9556/06/3412-2056-2063$20.00
DMD 34:2056-2063, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
dmd.106.010991v1
34/12/2056    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ninomiya, M.
Right arrow Articles by Horie, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ninomiya, M.
Right arrow Articles by Horie, T.

Functional Analysis of Mouse and Monkey Multidrug Resistance-Associated Protein 2 (Mrp2)Formula

Mizuki Ninomiya, Kousei Ito, Remi Hiramatsu, and Toshiharu Horie

Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University Chiba, Japan (M.N., R.H., T.H.); and Department of Pharmacy, the University of Tokyo Hospital, the University of Tokyo, Tokyo, Japan (K.I.)

We investigated the intrinsic transport activity of mouse and monkey Mrp2 and compared it with that of rat and dog Mrp2 reported previously. Mrp2 cDNAs were isolated from BALB/c and Macaca fascicularis liver, respectively, and vesicle transport studies were performed using recombinant Mrp2s expressed in insect Sf9 cells. ATP-dependent transport of [3H]leukotriene C4 (LTC4), 3[H]17ß-estradiol 17-(ß-D-glucuronide) (E217ßG), [3H]bromosulfophthalein (BSP), and [3H]cholecystokinin octapeptide (CCK-8) were readily detected for all Mrp2s. A species difference in the intrinsic transport activity was apparent for LTC4 (monkey > mouse, dog > rat) and BSP (rat, dog, monkey > mouse). In addition to the difference in the transport activity, complex kinetic profiles were also evident in CCK-8, where a cooperative transport site was observed. Moreover, the transport of [3H]E217ßG by mouse and monkey Mrp2 was quite different from that of rat and dog Mrp2 in that 1) there was practically only nonsaturable uptake for [3H]E217ßG and 2) 4-methylumbelliferon glucuronide (Mrp2 modulator) showed a concentration-dependent stimulatory effect on the transport of [3H]E217ßG in mouse and monkey Mrp2, whereas rat and dog transport activity was inhibited by the modulator. In conclusion, although the substrate specificity is similar, the intrinsic transport activity differs from one species to another. This is due not only to the difference in the Km and Vmax values, but also the qualitatively different mode of substrate and modulator recognition exhibited by different species.


Address correspondence to: Dr. Toshiharu Horie, Professor, Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba, 260-8675, Japan. E-mail: horieto{at}p.chibau.ac.jp




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
K. Heredi-Szabo, H. Glavinas, E. Kis, D. Mehn, G. Bathori, Z. Veres, L. Kobori, O. von Richter, K. Jemnitz, and P. Krajcsi
Multidrug Resistance Protein 2-Mediated Estradiol-17{beta}-D-glucuronide Transport Potentiation: In Vitro-in Vivo Correlation and Species Specificity
Drug Metab. Dispos., April 1, 2009; 37(4): 794 - 801.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
N. Li, Y. Zhang, F. Hua, and Y. Lai
Absolute Difference of Hepatobiliary Transporter Multidrug Resistance-Associated Protein (MRP2/Mrp2) in Liver Tissues and Isolated Hepatocytes from Rat, Dog, Monkey, and Human
Drug Metab. Dispos., January 1, 2009; 37(1): 66 - 73.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. Matsushima, K. Maeda, N. Ishiguro, T. Igarashi, and Y. Sugiyama
Investigation of the Inhibitory Effects of Various Drugs on the Hepatic Uptake of Fexofenadine in Humans
Drug Metab. Dispos., April 1, 2008; 36(4): 663 - 669.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. Zimmermann, K. van de Wetering, E. van de Steeg, E. Wagenaar, C. Vens, and A. H. Schinkel
Species-Dependent Transport and Modulation Properties of Human and Mouse Multidrug Resistance Protein 2 (MRP2/Mrp2, ABCC2/Abcc2)
Drug Metab. Dispos., April 1, 2008; 36(4): 631 - 640.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
K. Heredi-Szabo, E. Kis, E. Molnar, A. Gyorfi, and P. Krajcsi
Characterization of 5(6)-Carboxy-2,'7'-Dichlorofluorescein Transport by MRP2 and Utilization of this Substrate as a Fluorescent Surrogate for LTC4
J Biomol Screen, April 1, 2008; 13(4): 295 - 301.
[Abstract] [PDF]


Home page
CarcinogenesisHome page
E. M. Leslie, G. Ghibellini, K.-i. Nezasa, and K. L.R. Brouwer
Biotransformation and transport of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in bile duct-cannulated wild-type and Mrp2/Abcc2-deficient (TR ) Wistar rats
Carcinogenesis, December 1, 2007; 28(12): 2650 - 2656.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.